Smith C R, Butler J, Norman M R
Department of Chemical Pathology, King's College Hospital, Denmark Hill, London, UK.
Ann Clin Biochem. 1988 Sep;25 ( Pt 5):540-5. doi: 10.1177/000456328802500511.
Prolactin bioactivity was measured in sera from 22 patients with primary hypothyroidism and 13 euthyroid control subjects and compared with estimates of immunoactivity given by radioimmunoassay. The Nb2 rat lymphoma cell assay was modified to improve specificity for prolactin and used to measure bioactivity. Results of serum prolactin levels obtained using the bioassay were closely correlated with radioimmunoassay results in both hypothyroid patients and control subjects. Mean bioactivity/immunoactivity ratios in patients were not significantly different from those in control subjects. Mean prolactin concentration measured by both assays was significantly higher in patients than control subjects. Serum prolactin in patients with primary hypothyroidism appears to have essentially normal bioactivity as measured in the Nb2 assay, in contrast with a report of major differences between activity in radioreceptor assay and RIA in hypothyroid patients.
在22例原发性甲状腺功能减退患者和13例甲状腺功能正常的对照受试者的血清中测量催乳素生物活性,并与放射免疫分析给出的免疫活性估计值进行比较。对Nb2大鼠淋巴瘤细胞试验进行了改进,以提高对催乳素的特异性,并用于测量生物活性。在甲状腺功能减退患者和对照受试者中,使用生物测定法获得的血清催乳素水平结果与放射免疫分析结果密切相关。患者的平均生物活性/免疫活性比值与对照受试者无显著差异。两种测定方法测得的患者催乳素平均浓度均显著高于对照受试者。与一份关于甲状腺功能减退患者放射受体测定与放射免疫分析活性存在重大差异的报告相反,原发性甲状腺功能减退患者的血清催乳素在用Nb2试验测量时似乎具有基本正常的生物活性。